Showing 121-130 of 1779 results for "".
FDA Patient Safety News: Helping Healthcare Professionals Protect Patients
https://reachmd.com/programs/focus-on-pharmacy/fda-patient-safety-news-helping-healthcare-professionals-protect-patients/4851/The FDA periodically releases documents in print and on its website that are geared toward healthcare professionals. New drugs, medical devices, safety notifications and product recalls: all are meant to help healthcare professionals protect patients. But channeling information through only the prinPediatric Heart Transplantation: Ethical Questions
https://reachmd.com/programs/focus-on-heart-health/pediatric-heart-transplantation-ethical-questions/3655/Donation of the heart after asystole leads to questions about the point at which death is irreversible. Dr. Armand Antommaria, assistant professor in the division of pediatric inpatient medicine and an adjunct assistant professor in the division of medical ethics and humanities at the University ofTroubling Trends in Online Prescription Drug Sales
https://reachmd.com/programs/focus-on-pharmacy/troubling-trends-in-online-prescription-drug-sales/3430/We're learning more about the hundreds of Internet sites that advertise or sell controlled medications by mail. Yet a new set of answers brings a series of worrisome questions: How many of these websites actually require a prescription for controlled substances? Do many of those who buy prescriptionTools to Improve Patient Engagement in Health Care
https://reachmd.com/programs/lifelong-learning/tools-improve-patient-engagement-health-care/7335/"Patient engagement" is a broadly encompassing term that takes on various forms depending on the point of view, from the physician's drive toward better treatment compliance and health literacy to the patient's stance on being heard and understood through the care continuum. How can the medical profTraveling With Prescription Medications
https://reachmd.com/programs/FDA-Drug-Information-Updates/traveling-prescription-medications/7457/How can you avoid travel delays upon arrival to, and departure from, the United States? That’s a question patients often ask their local pharmacist or the FDA. FDA Drug Info Rounds pharmacists outline key points pharmacists should counsel their patients on prior to travel. Learn more of the FDA DruPrimary Causes of Back Pain
https://reachmd.com/programs/clinicians-roundtable/primary-causes-of-back-pain/3635/At some point nearly 85% of your patients below age 50 will present with back pain and nearly all of them will have at least one recurrence. Host Dr. Leslie Lundt welcomes Dr. Stuart McGill, professor of spine biomechanics and chair of the Department of Kinesiology at the University of Waterloo to rRecognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
https://reachmd.com/programs/neurofrontiers/program-name/36355/Multiple sclerosis (MS) presents a diverse range of symptoms that require coordinated, expert care. Dr. Marisa McGinley, a neurologist at the Cleveland Clinic, provides practical strategies for neurologists to serve as the central point of contact for patients with MS, initiate targeted treatments,Cutaneous Oncology Update: Dr. Ruiz
https://reachmd.com/programs/practical-dermatology/cutaneous-oncology-update-dr-ruiz/32696/Emily Ruiz, MD, discusses the key points she covered about nonmelanoma skin cancer during "Cutaneous Oncology Update 2025" at Maui Derm 2025, as well as her poster presentation on the 40-GEP test for head and neck cutaneous squamous cell carcinomas.First Cell-Based Gene Therapy for RDEB
https://reachmd.com/videos/dermwire-tv/first-cell-based-gene-therapy-for-rdeb/35742/In this week's DermwireTV, the FDA approves the first cell-based gene therapy for recessive dystophic epidermolysis bullosa (RDEB); a new acne scar treatment using focal point technology is cleared in the US; and in our “Updates on Skin Cancer” feature, we hear about the advantages of 40-GEP testingMedical Direction in CME Content Development
https://reachmd.com/programs/lifelong-learning/medical-direction-in-cme-content-development/6722/How do physicians provide oversight toward the development of CME content, and what are the criteria for ensuring content relevancy at the point of care? Host Lawrence Sherman is joined by Drs. Scott Hirshman and William Mencia to discuss these and other considerations for physician involvement in C